Glossary

1-(2’-deoxy-2’-fluoro-ß-D-arabinofuranosyl) uracil
A substance being studied in the treatment of advanced solid tumors and lymphomas. It blocks the growth of cells and may cause cancer cells to die. It is a type of uracil analog. Also called FAU.
1-(2’-deoxy-2’-fluoro-ß-D-arabinofuranosyl) uracil
A substance being studied in the treatment of advanced solid tumors and lymphomas. It blocks the growth of cells and may cause cancer cells to die. It is a type of uracil analog. Also called FAU.
1-(2’-deoxy-2’-fluoro-ß-D-arabinofuranosyl) uracil
A substance being studied in the treatment of advanced solid tumors and lymphomas. It blocks the growth of cells and may cause cancer cells to die. It is a type of uracil analog. Also called FAU.
1-(2’-deoxy-2’-fluoro-ß-D-arabinofuranosyl) uracil
A substance being studied in the treatment of advanced solid tumors and lymphomas. It blocks the growth of cells and may cause cancer cells to die. It is a type of uracil analog. Also called FAU.
1-(2’-deoxy-2’-fluoro-ß-D-arabinofuranosyl) uracil
A substance being studied in the treatment of advanced solid tumors and lymphomas. It blocks the growth of cells and may cause cancer cells to die. It is a type of uracil analog. Also called FAU.
1-(2’-deoxy-2’-fluoro-ß-D-arabinofuranosyl) uracil
A substance being studied in the treatment of advanced solid tumors and lymphomas. It blocks the growth of cells and may cause cancer cells to die. It is a type of uracil analog. Also called FAU.
1-(2’-deoxy-2’-fluoro-ß-D-arabinofuranosyl) uracil
A substance being studied in the treatment of advanced solid tumors and lymphomas. It blocks the growth of cells and may cause cancer cells to die. It is a type of uracil analog. Also called FAU.
1-(2’-deoxy-2’-fluoro-ß-D-arabinofuranosyl) uracil
A substance being studied in the treatment of advanced solid tumors and lymphomas. It blocks the growth of cells and may cause cancer cells to die. It is a type of uracil analog. Also called FAU.
1-methyl-d-tryptophan
A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT.
1-methyl-d-tryptophan
A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT.
1-methyl-d-tryptophan
A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT.
1-methyl-d-tryptophan
A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT.
1-methyl-d-tryptophan
A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT.
1-methyl-d-tryptophan
A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT.
1-methyl-d-tryptophan
A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT.
1-methyl-d-tryptophan
A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT.
10-propargyl-10-deazaaminopterin
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs.
10-propargyl-10-deazaaminopterin
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs.
10-propargyl-10-deazaaminopterin
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs.
10-propargyl-10-deazaaminopterin
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs.
10-propargyl-10-deazaaminopterin
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs.
10-propargyl-10-deazaaminopterin
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs.
10-propargyl-10-deazaaminopterin
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs.
10-propargyl-10-deazaaminopterin
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs.
11C topotecan
A substance being studied in the treatment of certain types of cancer, including ovarian cancer and lung cancer. 11C topotecan is a radioactive form of the anticancer drug topotecan. It builds up in tumor tissues and is detected by positron emission tomography (PET). It may be used to help determine whether treatment with topotecan will work. It is a type of topoisomerase I inhibitor.
11C topotecan
A substance being studied in the treatment of certain types of cancer, including ovarian cancer and lung cancer. 11C topotecan is a radioactive form of the anticancer drug topotecan. It builds up in tumor tissues and is detected by positron emission tomography (PET). It may be used to help determine whether treatment with topotecan will work. It is a type of topoisomerase I inhibitor.
11C topotecan
A substance being studied in the treatment of certain types of cancer, including ovarian cancer and lung cancer. 11C topotecan is a radioactive form of the anticancer drug topotecan. It builds up in tumor tissues and is detected by positron emission tomography (PET). It may be used to help determine whether treatment with topotecan will work. It is a type of topoisomerase I inhibitor.
11C topotecan
A substance being studied in the treatment of certain types of cancer, including ovarian cancer and lung cancer. 11C topotecan is a radioactive form of the anticancer drug topotecan. It builds up in tumor tissues and is detected by positron emission tomography (PET). It may be used to help determine whether treatment with topotecan will work. It is a type of topoisomerase I inhibitor.
11C topotecan
A substance being studied in the treatment of certain types of cancer, including ovarian cancer and lung cancer. 11C topotecan is a radioactive form of the anticancer drug topotecan. It builds up in tumor tissues and is detected by positron emission tomography (PET). It may be used to help determine whether treatment with topotecan will work. It is a type of topoisomerase I inhibitor.
11C topotecan
A substance being studied in the treatment of certain types of cancer, including ovarian cancer and lung cancer. 11C topotecan is a radioactive form of the anticancer drug topotecan. It builds up in tumor tissues and is detected by positron emission tomography (PET). It may be used to help determine whether treatment with topotecan will work. It is a type of topoisomerase I inhibitor.
11C topotecan
A substance being studied in the treatment of certain types of cancer, including ovarian cancer and lung cancer. 11C topotecan is a radioactive form of the anticancer drug topotecan. It builds up in tumor tissues and is detected by positron emission tomography (PET). It may be used to help determine whether treatment with topotecan will work. It is a type of topoisomerase I inhibitor.
11C topotecan
A substance being studied in the treatment of certain types of cancer, including ovarian cancer and lung cancer. 11C topotecan is a radioactive form of the anticancer drug topotecan. It builds up in tumor tissues and is detected by positron emission tomography (PET). It may be used to help determine whether treatment with topotecan will work. It is a type of topoisomerase I inhibitor.
12-O-tetradecanoylphorbol-13-acetate
A substance being studied in the treatment of leukemias and lymphomas. It is also being studied in the treatment of other types of cancer. 12-O-tetradecanoylphorbol-13-acetate affects many cell actions and may cause tumor cells to die. It is a type of phorbol ester. Also called tetradecanoylphorbol acetate and TPA.
12-O-tetradecanoylphorbol-13-acetate
A substance being studied in the treatment of leukemias and lymphomas. It is also being studied in the treatment of other types of cancer. 12-O-tetradecanoylphorbol-13-acetate affects many cell actions and may cause tumor cells to die. It is a type of phorbol ester. Also called tetradecanoylphorbol acetate and TPA.
12-O-tetradecanoylphorbol-13-acetate
A substance being studied in the treatment of leukemias and lymphomas. It is also being studied in the treatment of other types of cancer. 12-O-tetradecanoylphorbol-13-acetate affects many cell actions and may cause tumor cells to die. It is a type of phorbol ester. Also called tetradecanoylphorbol acetate and TPA.
12-O-tetradecanoylphorbol-13-acetate
A substance being studied in the treatment of leukemias and lymphomas. It is also being studied in the treatment of other types of cancer. 12-O-tetradecanoylphorbol-13-acetate affects many cell actions and may cause tumor cells to die. It is a type of phorbol ester. Also called tetradecanoylphorbol acetate and TPA.
12-O-tetradecanoylphorbol-13-acetate
A substance being studied in the treatment of leukemias and lymphomas. It is also being studied in the treatment of other types of cancer. 12-O-tetradecanoylphorbol-13-acetate affects many cell actions and may cause tumor cells to die. It is a type of phorbol ester. Also called tetradecanoylphorbol acetate and TPA.
12-O-tetradecanoylphorbol-13-acetate
A substance being studied in the treatment of leukemias and lymphomas. It is also being studied in the treatment of other types of cancer. 12-O-tetradecanoylphorbol-13-acetate affects many cell actions and may cause tumor cells to die. It is a type of phorbol ester. Also called tetradecanoylphorbol acetate and TPA.
12-O-tetradecanoylphorbol-13-acetate
A substance being studied in the treatment of leukemias and lymphomas. It is also being studied in the treatment of other types of cancer. 12-O-tetradecanoylphorbol-13-acetate affects many cell actions and may cause tumor cells to die. It is a type of phorbol ester. Also called tetradecanoylphorbol acetate and TPA.
12-O-tetradecanoylphorbol-13-acetate
A substance being studied in the treatment of leukemias and lymphomas. It is also being studied in the treatment of other types of cancer. 12-O-tetradecanoylphorbol-13-acetate affects many cell actions and may cause tumor cells to die. It is a type of phorbol ester. Also called tetradecanoylphorbol acetate and TPA.
126–F
A liquid that has been promoted as a treatment for a wide range of diseases, including cancer. The ingredients thought to be in 126–F have been tested, and none of them have been shown to be effective in treating any form of cancer. 126–F is not available in the United States. Also called Cancell, Cantron, Jim’s Juice, JS–101, JS–114, Protocel, and Sheridan’s Formula.
126–F
A liquid that has been promoted as a treatment for a wide range of diseases, including cancer. The ingredients thought to be in 126–F have been tested, and none of them have been shown to be effective in treating any form of cancer. 126–F is not available in the United States. Also called Cancell, Cantron, Jim’s Juice, JS–101, JS–114, Protocel, and Sheridan’s Formula.
126–F
A liquid that has been promoted as a treatment for a wide range of diseases, including cancer. The ingredients thought to be in 126–F have been tested, and none of them have been shown to be effective in treating any form of cancer. 126–F is not available in the United States. Also called Cancell, Cantron, Jim’s Juice, JS–101, JS–114, Protocel, and Sheridan’s Formula.
126–F
A liquid that has been promoted as a treatment for a wide range of diseases, including cancer. The ingredients thought to be in 126–F have been tested, and none of them have been shown to be effective in treating any form of cancer. 126–F is not available in the United States. Also called Cancell, Cantron, Jim’s Juice, JS–101, JS–114, Protocel, and Sheridan’s Formula.
126–F
A liquid that has been promoted as a treatment for a wide range of diseases, including cancer. The ingredients thought to be in 126–F have been tested, and none of them have been shown to be effective in treating any form of cancer. 126–F is not available in the United States. Also called Cancell, Cantron, Jim’s Juice, JS–101, JS–114, Protocel, and Sheridan’s Formula.
126–F
A liquid that has been promoted as a treatment for a wide range of diseases, including cancer. The ingredients thought to be in 126–F have been tested, and none of them have been shown to be effective in treating any form of cancer. 126–F is not available in the United States. Also called Cancell, Cantron, Jim’s Juice, JS–101, JS–114, Protocel, and Sheridan’s Formula.
126–F
A liquid that has been promoted as a treatment for a wide range of diseases, including cancer. The ingredients thought to be in 126–F have been tested, and none of them have been shown to be effective in treating any form of cancer. 126–F is not available in the United States. Also called Cancell, Cantron, Jim’s Juice, JS–101, JS–114, Protocel, and Sheridan’s Formula.
126–F
A liquid that has been promoted as a treatment for a wide range of diseases, including cancer. The ingredients thought to be in 126–F have been tested, and none of them have been shown to be effective in treating any form of cancer. 126–F is not available in the United States. Also called Cancell, Cantron, Jim’s Juice, JS–101, JS–114, Protocel, and Sheridan’s Formula.
13-cis retinoic acid
A drug that is used in the treatment of acne and psoriasis and is being studied in cancer prevention. It is a type of retinoid. Also called isotretinoin.
13-cis retinoic acid
A drug that is used in the treatment of acne and psoriasis and is being studied in cancer prevention. It is a type of retinoid. Also called isotretinoin.
13-cis retinoic acid
A drug that is used in the treatment of acne and psoriasis and is being studied in cancer prevention. It is a type of retinoid. Also called isotretinoin.
13-cis retinoic acid
A drug that is used in the treatment of acne and psoriasis and is being studied in cancer prevention. It is a type of retinoid. Also called isotretinoin.
13-cis retinoic acid
A drug that is used in the treatment of acne and psoriasis and is being studied in cancer prevention. It is a type of retinoid. Also called isotretinoin.
13-cis retinoic acid
A drug that is used in the treatment of acne and psoriasis and is being studied in cancer prevention. It is a type of retinoid. Also called isotretinoin.
13-cis retinoic acid
A drug that is used in the treatment of acne and psoriasis and is being studied in cancer prevention. It is a type of retinoid. Also called isotretinoin.
13-cis retinoic acid
A drug that is used in the treatment of acne and psoriasis and is being studied in cancer prevention. It is a type of retinoid. Also called isotretinoin.
131I-MIBG
A radioactive substance that is used in imaging tests, and is being studied in the treatment of cancer. It is a type of radiopharmaceutical. Also called iodine I 131 metaiodobenzylguanidine.
131I-MIBG
A radioactive substance that is used in imaging tests, and is being studied in the treatment of cancer. It is a type of radiopharmaceutical. Also called iodine I 131 metaiodobenzylguanidine.
131I-MIBG
A radioactive substance that is used in imaging tests, and is being studied in the treatment of cancer. It is a type of radiopharmaceutical. Also called iodine I 131 metaiodobenzylguanidine.
131I-MIBG
A radioactive substance that is used in imaging tests, and is being studied in the treatment of cancer. It is a type of radiopharmaceutical. Also called iodine I 131 metaiodobenzylguanidine.
131I-MIBG
A radioactive substance that is used in imaging tests, and is being studied in the treatment of cancer. It is a type of radiopharmaceutical. Also called iodine I 131 metaiodobenzylguanidine.
131I-MIBG
A radioactive substance that is used in imaging tests, and is being studied in the treatment of cancer. It is a type of radiopharmaceutical. Also called iodine I 131 metaiodobenzylguanidine.
131I-MIBG
A radioactive substance that is used in imaging tests, and is being studied in the treatment of cancer. It is a type of radiopharmaceutical. Also called iodine I 131 metaiodobenzylguanidine.
131I-MIBG
A radioactive substance that is used in imaging tests, and is being studied in the treatment of cancer. It is a type of radiopharmaceutical. Also called iodine I 131 metaiodobenzylguanidine.
1572 form
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial. The investigator verifies that he or she has the experience and background needed to conduct the trial and that it will be done in a way that is ethical and scientifically sound. Also called Form FDA 1572-Statement of Investigator.
1572 form
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial. The investigator verifies that he or she has the experience and background needed to conduct the trial and that it will be done in a way that is ethical and scientifically sound. Also called Form FDA 1572-Statement of Investigator.
1572 form
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial. The investigator verifies that he or she has the experience and background needed to conduct the trial and that it will be done in a way that is ethical and scientifically sound. Also called Form FDA 1572-Statement of Investigator.
1572 form
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial. The investigator verifies that he or she has the experience and background needed to conduct the trial and that it will be done in a way that is ethical and scientifically sound. Also called Form FDA 1572-Statement of Investigator.
1572 form
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial. The investigator verifies that he or she has the experience and background needed to conduct the trial and that it will be done in a way that is ethical and scientifically sound. Also called Form FDA 1572-Statement of Investigator.
1572 form
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial. The investigator verifies that he or she has the experience and background needed to conduct the trial and that it will be done in a way that is ethical and scientifically sound. Also called Form FDA 1572-Statement of Investigator.
1572 form
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial. The investigator verifies that he or she has the experience and background needed to conduct the trial and that it will be done in a way that is ethical and scientifically sound. Also called Form FDA 1572-Statement of Investigator.
1572 form
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial. The investigator verifies that he or she has the experience and background needed to conduct the trial and that it will be done in a way that is ethical and scientifically sound. Also called Form FDA 1572-Statement of Investigator.
17-AAG
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.
17-AAG
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.
17-AAG
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.
17-AAG
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.
17-AAG
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.
17-AAG
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.
17-AAG
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.
17-AAG
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.
17-dimethylaminoethylamino-17-demethoxygeldanamycin
17-DMAG. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called geldanamycin analogs.
17-dimethylaminoethylamino-17-demethoxygeldanamycin
17-DMAG. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called geldanamycin analogs.
17-dimethylaminoethylamino-17-demethoxygeldanamycin
17-DMAG. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called geldanamycin analogs.
17-dimethylaminoethylamino-17-demethoxygeldanamycin
17-DMAG. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called geldanamycin analogs.
17-dimethylaminoethylamino-17-demethoxygeldanamycin
17-DMAG. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called geldanamycin analogs.
17-dimethylaminoethylamino-17-demethoxygeldanamycin
17-DMAG. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called geldanamycin analogs.
17-dimethylaminoethylamino-17-demethoxygeldanamycin
17-DMAG. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called geldanamycin analogs.
17-dimethylaminoethylamino-17-demethoxygeldanamycin
17-DMAG. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called geldanamycin analogs.
17-N-allylamino-17-demethoxygeldanamycin
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.
17-N-allylamino-17-demethoxygeldanamycin
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.
17-N-allylamino-17-demethoxygeldanamycin
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.
17-N-allylamino-17-demethoxygeldanamycin
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.
17-N-allylamino-17-demethoxygeldanamycin
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.
17-N-allylamino-17-demethoxygeldanamycin
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.
17-N-allylamino-17-demethoxygeldanamycin
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.
17-N-allylamino-17-demethoxygeldanamycin
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.
18F-choline
A radioactive substance being studied in PET imaging to detect certain types of cancer. 18F-choline gets taken up by cells in the body and more of it is taken up by tumor cells than by normal cells. A PET scanner is used to detect which cells in the body have taken up 18F-choline. It is a type of radioimaging agent. Also called 18F-fluoromethylcholine, 18F-FMCH, and fluorine F 18 fluoromethylcholine.
18F-choline
A radioactive substance being studied in PET imaging to detect certain types of cancer. 18F-choline gets taken up by cells in the body and more of it is taken up by tumor cells than by normal cells. A PET scanner is used to detect which cells in the body have taken up 18F-choline. It is a type of radioimaging agent. Also called 18F-fluoromethylcholine, 18F-FMCH, and fluorine F 18 fluoromethylcholine.
18F-choline
A radioactive substance being studied in PET imaging to detect certain types of cancer. 18F-choline gets taken up by cells in the body and more of it is taken up by tumor cells than by normal cells. A PET scanner is used to detect which cells in the body have taken up 18F-choline. It is a type of radioimaging agent. Also called 18F-fluoromethylcholine, 18F-FMCH, and fluorine F 18 fluoromethylcholine.
18F-choline
A radioactive substance being studied in PET imaging to detect certain types of cancer. 18F-choline gets taken up by cells in the body and more of it is taken up by tumor cells than by normal cells. A PET scanner is used to detect which cells in the body have taken up 18F-choline. It is a type of radioimaging agent. Also called 18F-fluoromethylcholine, 18F-FMCH, and fluorine F 18 fluoromethylcholine.
Next Page